These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38943535)

  • 1. In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus.
    Sanchez L; Bitar M; Herail Q; Dorchêne D; Hugonnet JE; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2024 Jun; ():. PubMed ID: 38943535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of relebactam-mediated inhibition of Mycobacterium abscessus BlaMab β-lactamase on the in vitro and intracellular efficacy of imipenem.
    Le Run E; Atze H; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2020 Feb; 75(2):379-383. PubMed ID: 31637424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Lactamase inhibition by avibactam in Mycobacterium abscessus.
    Dubée V; Bernut A; Cortes M; Lesne T; Dorchene D; Lefebvre AL; Hugonnet JE; Gutmann L; Mainardi JL; Herrmann JL; Gaillard JL; Kremer L; Arthur M
    J Antimicrob Chemother; 2015 Apr; 70(4):1051-8. PubMed ID: 25525201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and intracellular activity of β-lactams against Mycobacterium abscessus.
    Lefebvre AL; Dubée V; Cortes M; Dorchêne D; Arthur M; Mainardi JL
    J Antimicrob Chemother; 2016 Jun; 71(6):1556-63. PubMed ID: 26929268
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Chen L; Shashkina E; Kurepina N; Calado Nogueira de Moura V; Daley CL; Kreiswirth BN
    Antimicrob Agents Chemother; 2024 May; 68(5):e0017424. PubMed ID: 38557171
    [No Abstract]   [Full Text] [Related]  

  • 6.
    Kaushik A; Ammerman NC; Lee J; Martins O; Kreiswirth BN; Lamichhane G; Parrish NM; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642943
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the β-Lactamase Bla
    Lefebvre AL; Le Moigne V; Bernut A; Veckerlé C; Compain F; Herrmann JL; Kremer L; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096155
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
    Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
    Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
    J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales.
    Bonnin RA; Bernabeu S; Emeraud C; Naas T; Girlich D; Jousset AB; Dortet L
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
    Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
    mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48.
    Asempa TE; Kois AK; Gill CM; Nicolau DP
    J Antimicrob Chemother; 2023 Mar; 78(3):636-645. PubMed ID: 36626311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48.
    Asempa TE; Kois AK; Gill CM; Nicolau DP
    J Antimicrob Chemother; 2022 Sep; 77(10):2622-2631. PubMed ID: 35325165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
    Lee SY; Gill CM; Nicolau DP;
    J Antimicrob Chemother; 2023 Dec; 78(12):2795-2800. PubMed ID: 37840005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors.
    Dousa KM; Kurz SG; Taracila MA; Bonfield T; Bethel CR; Barnes MD; Selvaraju S; Abdelhamed AM; Kreiswirth BN; Boom WH; Kasperbauer SH; Daley CL; Bonomo RA
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393499
    [No Abstract]   [Full Text] [Related]  

  • 17. An Appraisal of the Pharmacokinetic and Pharmacodynamic Properties of Meropenem-Vaborbactam.
    Wenzler E; Scoble PJ
    Infect Dis Ther; 2020 Dec; 9(4):769-784. PubMed ID: 33025557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of broad-spectrum Mycobacterium abscessus class A β-lactamase.
    Soroka D; Dubée V; Soulier-Escrihuela O; Cuinet G; Hugonnet JE; Gutmann L; Mainardi JL; Arthur M
    J Antimicrob Chemother; 2014 Mar; 69(3):691-6. PubMed ID: 24132992
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Economou Lundeberg E; Andersson V; Wijkander M; Groenheit R; Mansjö M; Werngren J; Cortes T; Barilar I; Niemann S; Merker M; Köser CU; Davies Forsman L
    Microbiol Spectr; 2023 Sep; 11(5):e0178123. PubMed ID: 37737628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The addition of avibactam renders piperacillin an effective treatment for
    Meir M; Bifani P; Barkan D
    Antimicrob Resist Infect Control; 2018; 7():151. PubMed ID: 30564307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.